Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Retinal Surface Contour is Predictive of Fast Glaucoma Progression with Deep Learning
Author Affiliations & Notes
  • Yan Luo
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Min Shi
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Yu Tian
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Mohammad Eslami
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Saber Kazeminasab Hashemabad
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Jessica A. Sun
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Aimee C. Chang
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Tobias Elze
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Lucy Q. Shen
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Louis R Pasquale
    Eye and Vision Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Nazlee Zebardast
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Michael Boland
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • David S. Friedman
    Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Mengyu Wang
    Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Yan Luo None; Min Shi None; Yu Tian None; Mohammad Eslami None; Saber Kazeminasab Hashemabad None; Jessica Sun None; Aimee Chang None; Tobias Elze Genentech, Code F (Financial Support); Lucy Shen Firecyte Therapeutics and Abbvie, Code C (Consultant/Contractor); Louis Pasquale Eyenovia-Advisory Board Member, Twenty-Twenty and Skye Biosciences, Code C (Consultant/Contractor); Nazlee Zebardast None; Michael Boland Carl Zeiss Meditec, Abbvie, Janssen, Topcon, Code C (Consultant/Contractor); David Friedman Genentech, Code F (Financial Support); Mengyu Wang Genentech, Code F (Financial Support)
  • Footnotes
    Support  NIH R00 EY028631, Research to Prevent Blindness International Research Collaborators Award, Alcon Young Investigator Grant, NIH R21 EY030631, NIH R01 EY030575, NIH R01 EY015473, NIH R21 EY031725, NIH R01 EY033005, and NIH P30 EY003790
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 338. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yan Luo, Min Shi, Yu Tian, Mohammad Eslami, Saber Kazeminasab Hashemabad, Jessica A. Sun, Aimee C. Chang, Tobias Elze, Lucy Q. Shen, Louis R Pasquale, Nazlee Zebardast, Michael Boland, David S. Friedman, Mengyu Wang; Retinal Surface Contour is Predictive of Fast Glaucoma Progression with Deep Learning. Invest. Ophthalmol. Vis. Sci. 2023;64(8):338.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We aim to further study if retinal surface contour (RSC) represented by inner limiting membrane at the optic nerve head is predictive of visual field (VF) progression using a deep learning model.

Methods : We selected reliable optical coherence tomography (OCT) scans from patients with at least 5 reliable 24-2 VFs over at least 4 years. We calculated 4 different VF progression outcomes: (1) mean deviation (MD) progression: MD slope < 0 and p-value < 0.05; (2) VF index (VFI) progression: VFI slope < 0 and p-value < 0.05; (3) total deviation (TD) pointwise progression: at least 3 TD locations with TD slope ≤ -1 dB/year and p-value < 0.05; (4) MD fast progression: MD slope ≤ -1 dB/year and p-value < 0.05. For each progression outcome, we built three deep learning models based on EfficientNet using the following inputs: (1) RNFLT map; (2) RSC map (Figure. 1); (3) RNFLT plus RSC maps. Our models were trained using two-thirds of the dataset and then tested using the remaining one-third with patient-level separation. T-test with bootstrapping sampling was used to compare the performance of different models measured by the area under the receiver operating characteristic curve (AUC).

Results : 16,155 OCT scans from 5,166 eyes of 3,115 patients with progression outcomes were included with 10,963 and 5,192 for training and testing, respectively. The average age and MD at baseline were 61.6 ± 13.0 years and -3.0 ± 4.1 dB, respectively. The progression percentages for MD progression, VFI progression, TD pointwise progression, and MD fast progression were 9.7%, 11.1%, 11.3%, and 2.6% with a median follow-time of 6.6 years, respectively. The AUCs of using RNFLT map, RSC map, and their combination for the four progression outcomes are as follows: (1) MD progression: 0.79, 0.69, and 0.81; (2) VFI progression: 0.81, 0.71, and 0.83; (3) TD pointwise progression: 0.84, 0.77 and 0.85; (4) MD fast progression: 0.76, 0.83 and 0.89 (Figure. 2). Combining RNFLT and RSC maps consistently performed better at predicting VF progression than using each of them alone. Although the RNFLT map generally outperformed the RSC map for progression prediction, the RSC map better predicted MD fast progression than the RNFLT map (AUCs: 0.83 versus 0.76, p < 0.001).

Conclusions : Combining RSC with RNFLT map can improve glaucoma progression prediction. RSC map is a better predictor of fast progression than the RNFLT map.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×